异常强大的奇拉尔安纳米德类似物
Markos-Orestis Georgiadis1, Elena Ferreras1, Lipin Ji1
1Center for Drug Discovery and Department of Pharmaceutical Sciences, Northeastern University, Boston, Massachusetts 02115, United States.
Journal of medicinal chemistry
|September 15, 2025
概括
研究人员开发了具有增强稳定性和功效的新型内分泌大麻素类似物. 新分子AM12814对CB1和CB2受体具有很高的亲和力,作为一种强有力的激动剂.
科学领域:
- 药用化学 医学化学
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 内大麻素是中枢神经系统中至关重要的信号分子.
- 现有的内分泌素如N-arachidonoylethanolamide和2-arachidonoylglycerol具有有限的代谢稳定性.
- 之前的工作引入了性中心,以增强内分泌大麻素的稳定性,导致AMG315.
研究的目的:
- 为了合成和优化AMG315.15的尾部修改的类似物.
- 为了提高对大麻素受体的结合亲和力和强度.
- 开发一种用于研究的新型内分泌大麻素探针.
主要方法:
- 基于AMG315.15的尾部修改类型的合成.
- 在体外功能性表征受体结合和活性.
- 在体内测试强度和疗效.
- 对CB1和CB2受体晶体结构进行分子对接研究.
主要成果:
- 标识AM12814 (20,20,20-三化物-(R) -N-(1-甲基-2-基乙基) -13-(S) -甲基-阿拉基多纳胺) 作为一种化合物.
- AM12814对CB1和CB2受体表现出前所未有的亲和力.
- 在实验室中,AM12814作为CB1和CB2受体的强有力的部分激动剂.
- 在体内,AM12814被证明是一个非常强效和有效的CB1激动剂.
结论:
- AMG315的尾部修改导致了AM12814的发现,它是一种强大的双重CB1/CB2受体激动剂.
- 与以前的类似物相比,AM12814具有更高的亲和力和疗效.
- 这种新型化合物作为一个有价值的工具来研究内分泌系统.
相关概念视频
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
2.0K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
2.0K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.8K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.8K
Opioid Analgesics: Synthetic and Semisynthetic Opioids
931
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
931
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.7K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.7K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
676
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
676
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
921
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
921


